Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot Q13315: Variant p.Gly2867Arg

Serine-protein kinase ATM
Gene: ATM
Feedback?
Variant information Variant position: help 2867 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance
Residue change: help From Glycine (G) to Arginine (R) at position 2867 (G2867R, p.Gly2867Arg). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from glycine (G) to large size and basic (R) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help -2 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page
Variant description: help In AT. Any additional useful information about the variant.


Sequence information Variant position: help 2867 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 3056 The length of the canonical sequence.
Location on the sequence: help EKRLAYTRSVATSSIVGYIL G LGDRHVQNILINEQSAELVH The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences. 
Human                         EKRLAYTRSVATSSIVGYILGLGDRHVQNILINEQSAELVH

Mouse                         EKRLAYTRSVATSSIVGYILGLGDRHVQNILINEQSAELVH

Pig                           ERRLAYTQSVATSSIVGYILGLGDRHVQNILINEQSAELVH

Caenorhabditis elegans        QKIINYRQSLATWSIVCYIVGLGDRHASNILFDQKLCTFVH

Drosophila                    ERRLAYTNSVATTSMVGYVLGLGDRHTQNILVDQQTAEVIH

Baker's yeast                 EAKKTYTKGVAASSIVGYILGLGDRHLNNILLDCSTGEPIH

Fission yeast                 TTQTNYARSTAVASVLGHVLGLGDRHGQNILIDKTSGEVIH
Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 2 – 3056 Serine-protein kinase ATM
Domain 2686 – 2998 PI3K/PI4K catalytic
Region 2867 – 2875 Catalytic loop
Mutagenesis 2870 – 2870 D -> A. Loss of kinase activity.
Mutagenesis 2875 – 2875 N -> K. Loss of kinase activity.



Literature citations
New mutations in the ataxia telangiectasia gene.
Baumer A.; Bernthaler U.; Wolz W.; Hoehn H.; Schindler D.;
Hum. Genet. 98:246-249(1996)
Cited for: VARIANT AT ARG-2867; Characterization of ATM gene mutations in 66 ataxia telangiectasia families.
Sandoval N.; Platzer M.; Rosenthal A.; Doerk T.; Bendix R.; Skawran B.; Stuhrmann M.; Wegner R.-D.; Sperling K.; Banin S.; Shiloh Y.; Baumer A.; Bernthaler U.; Sennefelder H.; Brohm M.; Weber B.H.F.; Schindler D.;
Hum. Mol. Genet. 8:69-79(1999)
Cited for: VARIANTS AT SER-570; CYS-785; GLY-1913; GLY-2016; ASP-2067; CYS-2227; ASP-2470; VAL-2662 DEL; PRO-2849 AND ARG-2867; VARIANTS CYS-49; LEU-858; ARG-1054; ASN-1853 AND VAL-1853;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.